Old Web
English
Sign In
Acemap
>
authorDetail
>
Sudhakar M. Pai
Sudhakar M. Pai
Princeton University
Pharmacokinetics
Medicine
Hemodialysis
end stage renal disease
Disease
5
Papers
6
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Thorough QT/QTc Evaluation of the Cardiac Safety of Enarodustat (JTZ-951), an Oral Erythropoiesis-Stimulating Agent, in Healthy Adults.
2021
Clinical pharmacology in drug development
Sudhakar M. Pai
Hiroyuki Yamada
Robert B. Kleiman
Rui Zhuo
Qingtao Mike Huang
Ryosuke Koretomo
Show All
Source
Cite
Save
Citations (0)
A Highly Sensitive and Selective UPLC-MS/MS Assay for the Determination of Enarodustat (JTZ-951) in Human Plasma
2021
Journal of Chromatography B
Sudhakar M. Pai
Mike (Qingtao) Huang
Koichi Maki
Michael Waldron
Tomonori Yoshikawa
Tara Keller
James Burnett
Show All
Source
Cite
Save
Citations (0)
Hemodialysis Clearance of Enarodustat (JTZ-951), an Oral Erythropoiesis Stimulating Agent, in Patients with End-Stage Renal Disease.
2021
Clinical pharmacology in drug development
Sudhakar M. Pai
Hiroyuki Yamada
Show All
Source
Cite
Save
Citations (0)
Pharmacokinetics of Lapatinib, a Nonrenally Cleared Drug, in Patients With End-Stage Renal Disease on Maintenance Hemodialysis.
2019
The Journal of Clinical Pharmacology
Sudhakar M. Pai
Philip Chaikin
Jolene Kay Berg
Show All
Source
Cite
Save
Citations (0)
A Mass Balance Study of 14C‐Labeled JTZ‐951 (Enarodustat), a Novel Orally Available Erythropoiesis‐Stimulating Agent, in Patients With End‐Stage Renal Disease on Hemodialysis
2019
Clinical pharmacology in drug development
Sudhakar M. Pai
Jeffrey Connaire
Hiroyuki Yamada
Seiji Enya
Barbara Gerhardt
Michihide Maekawa
Hiromasa Tanaka
Ryosuke Koretomo
Tomohiro Ishikawa
Show All
Source
Cite
Save
Citations (6)
1